Editas Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:8EM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Dec 24	Sell€1,069	Baisong Mei	Individual	541	€1.98
03 Dec 24	Sell€3,198	Gilmore O’Neill	Individual	1,618	€1.98
04 Sep 24	Sell€4,806	Gilmore O’Neill	Individual	1,555	€3.09
04 Sep 24	Sell€1,601	Baisong Mei	Individual	518	€3.09
25 Jul 24	Sell€59,278	Linda Burkly	Individual	11,886	€4.99
19 Jul 24	Sell€31,648	Baisong Mei	Individual	6,619	€4.78
04 Jun 24	Sell€2,581	Baisong Mei	Individual	511	€5.05
04 Jun 24	Sell€61,570	Gilmore O’Neill	Individual	12,191	€5.05
20 May 24	Sell€115,460	Erick Lucera	Individual	22,337	€5.17
13 May 24	Buy€235,208	Jessica Hopfield	Individual	45,000	€5.23
05 Mar 24	Sell€674,400	Gilmore O’Neill	Individual	77,824	€8.67
04 Mar 24	Sell€176,245	Baisong Mei	Individual	20,327	€8.67

Insider Trading Volume

Insider Buying: 8EM insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 8EM?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	326,095	0.395%
VC/PE Firms	4,900,334	5.94%
General Public	25,955,371	31.4%
Institutions	51,366,299	62.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 54.85% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.72%	BlackRock, Inc.	8,024,709	€9.3m	3.11%	no data
8.09%	The Vanguard Group, Inc.	6,679,606	€7.8m	-16.8%	no data
5.94%	Deep Track Capital, LP	4,900,334	€5.7m	-18.3%	0.2%
4.06%	Millennium Management LLC	3,350,856	€3.9m	36.2%	no data
2.98%	State Street Global Advisors, Inc.	2,462,022	€2.9m	-46.4%	no data
2.75%	Dimensional Fund Advisors LP	2,267,110	€2.6m	-3.32%	no data
2.29%	Geode Capital Management, LLC	1,887,696	€2.2m	-3.97%	no data
1.77%	Avidity Partners Management, L.P.	1,465,000	€1.7m	79.5%	0.11%
1.65%	Two Sigma Investments, LP	1,358,589	€1.6m	151%	no data
1.58%	UBS Asset Management AG	1,308,142	€1.5m	5.18%	no data
1.4%	Pictet Asset Management Limited	1,155,937	€1.3m	-19%	no data
1.37%	Two Sigma Advisers, LP	1,129,000	€1.3m	31.8%	no data
1.27%	Morgan Stanley, Investment Banking and Brokerage Investments	1,046,890	€1.2m	25.7%	no data
1.09%	Woodline Partners LP	900,421	€1.0m	-7.22%	0.01%
1.05%	Jane Street Group, LLC, Asset Management Arm	863,764	€1.0m	198%	no data
0.98%	Bank of America Corporation, Asset Management Arm	808,610	€940.1k	53.8%	no data
0.88%	Point72 Asset Management, L.P.	727,132	€845.3k	0%	no data
0.88%	JP Morgan Asset Management	725,311	€843.2k	-3.86%	no data
0.85%	Northern Trust Global Investments	703,799	€818.2k	-4.55%	no data
0.77%	Goldman Sachs Group, Investment Banking and Securities Investments	635,701	€739.0k	-3.1%	no data
0.76%	Stifel Asset Management Corp.	624,876	€726.5k	37.9%	no data
0.75%	Charles Schwab Investment Management, Inc.	617,280	€717.6k	-15.8%	no data
0.68%	Raymond James Financial Inc., Asset Management Arm	561,371	€652.6k	6.56%	no data
0.65%	Kennedy Capital Management LLC	540,135	€627.9k	307%	0.02%
0.64%	Goldman Sachs Asset Management, L.P.	531,493	€617.9k	-5.54%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 03:57
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Editas Medicine, Inc. is covered by 34 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Joel Beatty	Baird
Huidong Wang	Barclays